404
+1-313-307-4176
Transforming Growth Factor Beta 1 Market Report
Global Transforming Growth Factor-Beta 1 Market, Dynamics, and Market Analysis
The report on the global Transforming Growth Factor-Beta 1 Market is segmented by Product (Pirfenidone, Galunisertib, Others), Application (Idiopathic Pulmonary Fibrosis (IPF), Cancer, Others), and Region. This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global Transforming Growth Factor Beta 1 market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
The Global Transforming Growth Factor-Beta 1 Market is expected to grow from USD 1.1 billion in 2020 to USD 2.0 billion by 2026 at a CAGR of over 11.1% during the forecast period.
Figure: Global Transforming Growth Factor-Beta 1 Market Size, 2020-2026 (USD Billion)
Wish to get a sample report? Click here
Transforming growth factor-beta 1 is a multifunctional regulatory polypeptide member of the growth factor-beta family of cytokines. It is defined as a protein that performs various cellular functions including cell differentiation, cell growth, cell proliferation, and apoptosis. It also plays an important role in pathologic processes.
Key players operating in the global Transforming Growth Factor-Beta 1 Market are-
The growth of the global transforming growth factor-beta 1 market is primarily driven by its increasing usage in treating diseases such as cancer and idiopathic pulmonary fibrosis.
Based on application, the market has been segmented into idiopathic pulmonary fibrosis (IPF), cancer, and others. Idiopathic pulmonary fibrosis (IPF) is a chronic and ultimately fatal lung disease. The idiopathic pulmonary fibrosis segment accounted for the largest market share in 2020. The cancer segment is projected to register a higher CAGR during the review period on account of the increasing prevalence of cancer among people.
Geographically, the market in Europe accounted for the largest market share in 2020 and is expected to grow at a steady rate during the review period.
The outbreak of covid-19 across regions led to the imposition of lockdown across geographies, border restrictions, and the breakdown of the transportation network. This resulted in the closure of factories which break affected the market growth. The ongoing treatment of the patients with cancer and IPF diseases was not affected due to the covid-19 outbreak as people were allowed to go out for medical emergencies.
Want to know the full scope of the report? Register Here
Here is the list of the group of customers that the Global transforming growth factor-Beta 1 market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].
The report is delivered digitally through our online portal. Buyers receive login credentials from our team to access the report and may update their credentials at any time after the initial login.
Delivery timelines depend on the status of the report:
For the most accurate delivery timeline, please contact us to confirm the current status of the report.
Yes. You may request a complimentary preview of the report through a video conference with our team.
Yes. The scope of the report can be fully customized to align with your specific research objectives and information requirements.
Please contact us at [email protected], and our team will be happy to discuss your requirements and propose a tailored solution.
Yes. Selected sections of the report can be purchased separately based on your requirements. Please contact us at [email protected] to discuss your needs.
Yes, AI can help gather publicly available information, but its outputs are only as reliable as the data it accesses. Stratview Research reports are built using validated data, extensive primary interviews with industry stakeholders, and the expertise of our experienced research team.
Additionally, many critical insights, including market dynamics, competitive intelligence, and industry-specific trends, are not publicly available and therefore cannot be captured through AI alone.
The transforming growth factor beta 1 market size is expected to reach USD 2.0 billion in the foreseeable future.
F. Hoffmann-La Roche AG (Switzerland), Shionogi & Company, Limited (Japan), Isarna Holding GmbH (Germany), Scholar Rock Holding (The U.S), Acceleron Pharma, Inc. (The U.S), Sanofi Genzyme (The U.S), Sirnaomics, Inc. (The U.S), Eli Lilly and Company (The U.S), Novartis International AG (Switzerland) and Formation Biologics Inc. (The U.S) are among the key players in the transforming growth factor beta 1 market.
The transforming growth factor beta 1 market is expected to witness an impressive growth of 11.1% CAGR in the coming years.
Europe accounted for the largest share of transforming growth factor beta 1 market in 2020.
The idiopathic pulmonary fibrosis segment is expected to register higher CAGR in the transforming growth factor beta 1 market in the coming years.
Increasing usage in treating diseases such as cancer and idiopathic pulmonary fibrosis, increasing number of people suffering from various cancers, Growing emphasis on investment in R&D activities are the factors driving the growth of transforming growth factor beta 1 market.
Transforming growth factor beta 1 manufacturers, Transforming growth factor beta 1 suppliers, Transforming growth factor beta 1 distributors, Organizations, Government bodies are the target audience in the transforming growth factor beta 1 market.
WE ACCEPT
